Register now
To access the site, please provide the required information to verify that you are a Canadian healthcare professional and create an account. Once validated, this account can be used to log in to all myAstraZeneca websites for Canadian healthcare professionals. Please use the first and last name registered with your professional college.
SAPHNELO – Dosing and Administration
30-minute intravenous infusion, once every 4 weeks1
SAPHNELO solution for infusion should be prepared and administered by a health professional trained to give infusion therapy, using aseptic technique. It should not be administered as an IV push or bolus injection.
SAPHNELO is administered as follows:
Please see the SAPHNELO Product Monograph for complete dosing and administration information.
IV=intravenous.
SAPHNELO is administered from 100 mL infusion bag:
Health professionals should be prepared to manage hypersensitivity reactions, including anaphylaxis, and infusion-related reactions. The infusion rate may be slowed or interrupted if the patient develops an infusion reaction. If a serious infusion-related or hypersensitivity reaction (e.g., anaphylaxis) occurs, immediately interrupt the administration of SAPHNELO and initiate appropriate therapy.
Please see the SAPHNELO Product Monograph for complete dosing and administration information.
IV=intravenous.
SAPHNELO® and the AstraZeneca logo are registered trademarks of, and Connect360TM is a trademark of, AstraZeneca AB, used under license by AstraZeneca Canada Inc.
